Abstract
Helix-loop-helix (HLH) proteins are transcriptional regulators that control a wide variety of developmental pathways in both invertebrate and vertebrate organisms. Results obtained in the past decade have shown that HLH proteins also contribute to the development of lymphoid lineages. A subset of HLH proteins, the 'E proteins', seems to be particularly important for proper lymphoid development. Members of the E protein family include E12, E47, E2-2 and HEB. The E proteins contribute to B lineage– and T lineage–specific gene expression programs, regulate lymphocyte survival and cellular proliferation, activate the rearrangement of antigen receptor genes and control progression through critical developmental checkpoints. This review discusses HLH proteins in lymphocyte development and homeostasis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
An autonomous TCR signal-sensing switch influences CD4/CD8 lineage choice in mice
Communications Biology Open Access 21 January 2022
-
Transcription tipping points for T follicular helper cell and T-helper 1 cell fate commitment
Cellular & Molecular Immunology Open Access 30 September 2020
-
Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren’s syndrome
Cell Death & Disease Open Access 05 March 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Lazorchak, A., Jones, M.E. & Zhuang, Y. New insights into E-protein function in lymphocyte development. Trends Immunol. 26, 334–338 (2005).
Sun, X.H. Multitasking of helix-loop-helix proteins in lymphopoiesis. Adv. Immunol. 84, 43–77 (2004).
Bain, G., Gruenwald, S. & Murre, C. E2A and E2–2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol. Cell. Biol. 13, 3522–3529 (1993).
Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R. & Kadesch, T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol. 16, 6900–6908 (1996).
Shen, C.P. & Kadesch, T. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15, 4518–4524 (1995).
Sawada, S. & Littman, D.R. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13, 5620–5628 (1993).
Murre, C., McCaw, P.S. & Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777–783 (1989).
Aronheim, A., Shiran, R., Rosen, A. & Walker, M.D. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. USA 90, 8063–8067 (1993).
Quong, M.W., Massari, M.E., Zwart, R. & Murre, C. A new transcriptional-activation motif restricted to class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13, 792–800 (1993).
Massari, M.E., Jennings, P.A. & Murre, C. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16, 121–129 (1996).
Sun, X.H. & Baltimore, D. An inhibitory domain of the E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64, 459–470 (1991).
Massari, M.E. & Murre, C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429–440 (2000).
Corneliussen, B., Thornell, A., Hallberg, B. & Grundstrom, T. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65, 6084–6093 (1991).
Rothenberg, E.V. (2002). T-lineage specification and commitment: a gene regulation perspective. Sem. Immunol. 14, 431–440 (2002).
Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49–59 (1990).
Norton, J.D. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897–3905 (2000).
Yan, W. et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17, 7317–7327 (1997).
Rivera, R.R., Johns, C.P., Quan, J., Johnson, R.S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17–26 (2000).
Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702–706 (1999).
Pan, L., Sato, S., Frederick, J.P., Sun, X.H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19, 5969–5980 (1999).
Ikawa, T., Kawamoto, H., Wright, L.Y.T. & Murre, C. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 3, 349–360 (2004).
Massari, M.E. et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4, 63–73 (1999).
Qiu, Y., Sharma, A. & Stein, R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol. Cell. Biol. 18, 2957–2964 (1998).
Bradney, C. et al. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278, 2370–2376 (2002).
Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T. & Roeder, R.G. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286–1289 (2004).
Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21, 759–806 (2003).
Allman, D. et al. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4, 168–174 (2003).
Schwartz, B.A. & Bhandoola, A. Circulating hematopoietic progenitors with T lineage potential. Nat. Immunol. 5, 953–960 (2004).
Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547–558 (1999).
Pui, J.C. et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11, 299–308 (1999).
Rothenberg, E.V. & Taghon, T. Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601–649 (2005).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884 (1994).
Sun, X.H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893–900 (1994).
Heemskerk, M.H. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix-loop-helix factor Id3. J. Exp. Med. 186, 1597–1602 (1997).
Bain, G. et al. E2A deficiency leads to abnormalities in T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782–4791 (1997).
Barndt, R.J., Dai, M. & Zhuang, Y. Functions of E2A/HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol. Cell. Biol. 20, 6677–6685 (2000).
Spits, H., Couwenberg, F., Bakker, A.Q., Weijer, K. & Uittenbogaart, C.H. Id2 and Id3 inhibit development of CD34+ stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775–1784 (2000).
Zhuang, Y., Jackson, A., Pan, L., Shen, K. & Dai, M. Regulation of E2A gene expression in B lymphocyte development. Mol. Immunol. 40, 1165–1170 (2004).
Shivdasani, R.A., Mayer, E.L. & Orkin, S.H. Absence of blood formation in mice lacking the T-cell leukemia protein tal-1/SCL. Nature 373, 432–443 (1995).
Ying, Q., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281–292 (2003).
Igarashi, H., Gregory, S., Yokota, T., Sakaguchi, N. & Kincade, P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117–130 (2002).
Singh, H., Medina, K.L. & Pongubala, J.M.R. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102, 4945–4953 (2005).
Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55–79 (2004).
Jaleco, A.C. et al. Genetic modification of human B cell development: B cell development is inhibited by the dominant-negative helix-loop-helix factor Id3. Blood 94, 2637–2646 (1999).
Bain, G. et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6, 145–154 (1997).
Zhuang, Y., Cheng, P. & Weintraub, H. B lymphocyte development is regulated by the combined dosage of three helix-loop-helix genes, E2A, E2–2 and HEB. Mol. Cell. Biol. 16, 2898–2905 (1996).
Hagman, J., Belanger, C., Travis, A., Turck, C.W. & Grosschedl, R. Cloning and characterization of early B-cell factor, a regulator of lymphocyte specific gene expression. Genes Dev. 5, 760–773 (1993).
Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263–267 (1995).
Urbanek, P., Wang, Z., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).
Hesslein, D.G. et al. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 1, 37–42 (2003).
Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689–1700 (2004).
Kee, B.L. & Murre, C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188, 699–713 (1998).
O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21–31 (1999).
Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556–562 (1999).
Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069–1077 (2004).
Quong, M.W. et al. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J. Exp. Med. 199, 1113–1120 (2004).
Greenbaum, S., Lazorchak, A.S. & Zhuang, Y. Differential functions for the transcription factor E2A in positive and negative regulation in pre-B lymphocytes. J. Biol. Chem. 279, 45028–45035 (2004).
Schebesta, M., Pfeffer, P.L. & Busslinger, M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17, 473–485 (2002).
Herblot, S., Aplan, P.D. & Hoang, T. Gradient of E2A activity in B cell development. Mol. Cell. Biol. 22, 886–900 (2002).
Hsu, L. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105–117 (2003).
Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343–353 (2000).
Inlay, M.A., Tian, H., Lin, T. & Xu, Y. Important roles for E protein binding sites within the immunoglobulin κ chain intronic enhancer in activating VJk rearrangement. J. Exp. Med. 9, 1205–1211 (2004).
Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and EBF in non lymphoid cells. J. Exp. Med. 194, 645–656 (2001).
Bain, G. Romanow, W.J., Albers, K. Havran, W.L. & Murre, C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 189, 289–300 (1999).
Bergman, Y. & Cedar, H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat. Rev. Immunol. 4, 753–761 (2004).
Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1, 31–36 (2000).
Tanigaki, K. et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3, 443–450 (2002).
Quong, M.W., Harris, D.P., Swain, S.L. & Murre, C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18, 6307–6318 (1999).
Sayegh, C.E., Quong, M.E., Agata, Y. & Murre, C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586–593 (2003).
Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235–242 (2003).
Goldfarb, A.N., Flores, J.P. & Lewandowska, K. Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. Mol. Immunol. 33, 947–956 (1996).
Roberts, V.J., Steenbergen, R. & Murre, C. Localization of E2A mRNA expression in developing and adult rat tissues. Proc. Natl. Acad. Sci. USA 90, 7583–7587 (1993).
Gonda, H. et al. The balance between Pax5 and Id2 activities is the key to AID expression. J. Exp. Med. 198, 1427–1437 (2003).
Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y. & Yokota, Y. Commitment to natural killer cells requires the helix-loop-helix protein, Id2. Proc. Natl. Acad. Sci. USA 98, 5164–5169 (2001).
Hacker, C. et al. Transcription profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4, 380–386 (2003).
Engel, I., Johns, C., Bain, G., Rivera, R.R. & Murre, C. Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194, 733–745 (2001).
Herblot, S. et al. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression. Nat. Immunol. 1, 138–144 (2000).
Schlissel, M., Voronova, A. & Baltimore, D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5, 1367–1376 (1991).
Engel, I. & Murre, C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23, 202–211 (2004).
Bain, G., Quong, M.W., Soloff, R.S., Hedrick, S.M. & Murre, C. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J. Exp. Med. 190, 1605–1616 (1999).
Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165–171 (2001).
Costello, P.S., Nicolas, R.H., Watanabe, Y., Rosewell, I. & Treisman, R. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5, 289–298 (2004).
Bettini, M., Xi, H., Milbrandt, J. & Kersh, G.J. Thymocyte development in early growth response gene 1-deficient mice. J. Immunol. 169, 1713–1720 (2002).
Kee, B.L., Rivera, R.R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2, 242–247 (2001).
Hollnagel, A., Oehlmann, V., Heymeyer, J., Ruther, U. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838–19845 (1999).
Frasca, D., Nguyen, D., Riley, R.L. & Blomberg, B.B. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J. Immunol. 170, 719–726 (2003).
Van der Put, E., Frasca, D., King, A.M., Blomberg, B.B. & Riley, R.L. Decreased E47 in senescent B cell precursors is stage-specific and regulated posttranslationally by protein turn-over. J. Immunol. 173, 818–827 (2004).
Li, H., Dai, M. & Zhuang, Y.A. T cell intrinsic role in a mouse model for primary Sjogren's syndrome. Immunity 21, 551–560 (2004).
Taghon, T.N., David, E., Zuniga-Pflucker, J.C. & Rothenberg, E.V. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965–978 (2005).
Bailey, A.M. & Posakony, J.W. Suppressor hairless directly activates transcription of Enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 9, 2609–2622 (1995).
Murre, C. et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537–544 (1989).
Ordentlich, P. et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18, 2230–2239 (1998).
Nie, L., Xu, M., Vladimirova, A. & Sun, X.H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22, 5780–5792 (2003).
Huang, Z., Nie, L., Xu, M. & Sun, X.H. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol. Cell. Biol. 24, 8951–8962 (2004).
Engel, I. & Murre, C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl. Acad. Sci. USA 96, 996–1001 (1999).
Kee, B.L., Bain, G. & Murre, C. Il-7Rα and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21, 103–113 (2002).
Kim, D., Peng, X.C. & Sun, X.H. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell. Biol. 19, 8240–8253 (1999).
Zhao, F., Vilardi, A., Neely, R.J. & Choi, J.K. Promotion of cell cycle progression by basic helix–loop–helix E2A. Mol. Cell. Biol. 21, 6346–6357 (2001).
Peverali, F. et al. Regulation of G1 progression by E2A and Id helix–loop–helix proteins. EMBO J. 13, 4291–4301 (1994).
Sicinska, E. et al. Requirements for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4, 451–456 (2003).
Morrow, M.A., Mayer, E.W., Perez, C.A., Adlam, M. & Siu, G. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491–503 (1999).
Park, S.T., Nolan, G.P. & Sun, X.H. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J. Exp. Med. 189, 501–508 (1999).
Engel, I. & Murre, C. 1999. Transcription factors in hematopoiesis. Curr. Opin. Genet. Dev. 9, 575–579 (1999).
O'Neil, J., Shank, J., Cusson, N., Murre, C. & Kelliher, M. 2004. TAL1/SCL induces leukemia by inhibiting transcriptional activity of E47/HEB. Cancer Cell 5, 587–597 (2004).
Aspland, S.E., Bendall, H.H. & Murre, C. The role of E2A/Pbx-1 in leukemogenesis. Oncogene 20, 5708–5717 (2001).
Look, A.T. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastoid leukemia. Curr. Top. Microbiol. Immunol. 220, 45–53 (1997).
Asp, J., Thornemo, M., Inerot, S. & Lindahl, A. The helix-loop-helix transcription factors Id1 and Id3 have a functional role in control of cell division in human normal and neoplastic chondrocytes. FEBS Lett. 438, 85–90 (1998).
Nishimori, H. et al. The Id2 gene is a novel target of transcriptional activation by ES-ETS fusion proteins in Ewing family tumors. Oncogene 21, 8302–8309 (2002).
Rockman, S.P. et al. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276, 45113–45119 (2001).
Perk, J., Iavarone, A. & Benezra, R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603–614 (2005).
Acknowledgements
I thank A. Goldrath and members of my laboratory for critical reading of the manuscript.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Murre, C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 6, 1079–1086 (2005). https://doi.org/10.1038/ni1260
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1260
This article is cited by
-
An autonomous TCR signal-sensing switch influences CD4/CD8 lineage choice in mice
Communications Biology (2022)
-
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation
Journal of NeuroVirology (2022)
-
Transcription tipping points for T follicular helper cell and T-helper 1 cell fate commitment
Cellular & Molecular Immunology (2021)
-
Cellular networks controlling T cell persistence in adoptive cell therapy
Nature Reviews Immunology (2021)
-
Zeb1 represses TCR signaling, promotes the proliferation of T cell progenitors and is essential for NK1.1+ T cell development
Cellular & Molecular Immunology (2021)